{
    "2018-04-13": [
        [
            {
                "time": "",
                "original_text": "益丰药店今日大宗交易成交58万股，成交价61.33元折价0.0%。",
                "features": {
                    "keywords": [
                        "益丰药店",
                        "大宗交易",
                        "成交价"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药股要走出低谷了。",
                "features": {
                    "keywords": [
                        "医药股",
                        "低谷"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级]广东零售药店政策点评：政策监管趋严 利好连锁药店龙头。",
                "features": {
                    "keywords": [
                        "广东",
                        "零售药店",
                        "政策监管",
                        "连锁药店",
                        "龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]医药生物行业简评：分类分级管理即将上线 广东连锁药店开启新篇章。",
                "features": {
                    "keywords": [
                        "医药生物",
                        "分类分级管理",
                        "广东",
                        "连锁药店"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "[买入评级]医药生物行业简报：广东省药店管理重大改革 有助药店龙头加速整合。",
                "features": {
                    "keywords": [
                        "医药生物",
                        "广东省",
                        "药店管理",
                        "改革",
                        "龙头",
                        "整合"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "政策利好+业绩超预期 医药股显防御特征。",
                "features": {
                    "keywords": [
                        "政策利好",
                        "业绩超预期",
                        "医药股",
                        "防御特征"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-04-13",
                "original_text": "4月13日券商晨会研报汇编。",
                "features": {
                    "keywords": [
                        "券商晨会",
                        "研报汇编"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "重量级券商新进这些重仓股。",
                "features": {
                    "keywords": [
                        "重量级券商",
                        "重仓股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药股获资金追捧显防御本色 六股成摇钱树。",
                "features": {
                    "keywords": [
                        "医药股",
                        "资金追捧",
                        "防御本色",
                        "六股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药股显防御本色 近八成医药公司一季报业绩预喜。",
                "features": {
                    "keywords": [
                        "医药股",
                        "防御本色",
                        "一季报",
                        "业绩预喜"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}